Cancer is the second-leading cause of death in the United States. More than 1,500 Americans a day die from this disease - one out of every four deaths in this country. Cancer's financial toll is staggering. The National Institutes of Health estimate that overall costs for cancer in the year 2003 were $189.5 billion, including $64.2 billion in direct medical costs. As America's population ages, incidences of cancer are likely to increase, since cancer is much more common in the elderly than in the young. As diagnostic technology improves and more treatment options become available, survival rates are improving. As new oncology pharmaceuticals and supportive care drugs are introduced into the marketplace, the costs of treating cancer patients continue to rise. Improved survival rates also mean that many patients receive treatment for longer periods of time, increasing costs and the challenges of managing ever-increasing patient loads. Current industry estimates predict that pharmaceutical use will continue to increase. The U.S. Cancer pharmaceuticals market is projected to exceed $30 billion in 2010. The delivery of cancer care services continues to be a locally based healthcare service. The market players continue to be fragmented at the local level and consist of hospitals or other oncology practices. Knowledge Source's Cancer Centers Market Overview, 210 pages in length, provides an understanding of the market for cancer centers and the trends which affect it. Knowledge Source's Cancer Centers Market Overview also provides brief profiles on a thirty-five cancer centers. Knowledge Source's Cancer Centers Market Overview provides information on each Cancer Center which includes (when available): organization background, organization strategy, products/services and recent activities. | 
Scroll to this section
Healthcare Market Overviews